.Turnstone Biologics is actually reducing its own headcount through 60% and also agitating its C-sui...
.In a year that has observed a permission and a boating of readouts for metabolic dysfunction-associ...
.Alaunos Rehabs is axing an agreement with Precigen, losing hope licensing civil liberties to an ind...
.Capricor Therapeutics is taking a victory lap for their stage 2 Duchenne muscular dystrophy (DMD) t...
.The FDA has placed Kezar Life Sciences' lupus trial on grip after the biotech flagged 4 deaths in t...
.A period 3 trial of Scholar Stone's spinal muscular degeneration (SMA) candidate has actually hit i...
.RNA biotech CAMP4 Therapies has defined plans for a $67 thousand IPO, with inflammation-focused Ups...
.A year after the breakdown of an idiopathic pulmonary fibrosis prospect delivered Galecto on a seek...
.Taking the mat is Judo Bio, a promising biotech armed with $one hundred million to build oligonucle...
.AstraZeneca has paid off CSPC Drug Team $100 thousand for a preclinical cardiovascular disease drug...